Network News 13 – January 2004

NETWORK NEWS FLASHES Advocates Build Joint Agenda for HIV Microbicides, Treatments and Vaccines Amendment to Canada’s Patent Act: More Work Needed Network Participates in Drafting of Warsaw Declaration A Plan of Action for Canada to Reduce HIV/AIDS-related Stigma and Discrimination Mobilizing Communities to Take Action on Stigma and Discrimination Thai Network of Drug Users Extends … Read more

HIV Treatments, Microbicides and Vaccines: Developing an agenda for action – Background Paper

This paper proposes discussion points relevant to the development of a plan of action to support collaborative advocacy. It is a shorter, more accessible version of the Background Paper for advocacy organizations and individuals involved in HIV vaccine, microbicide and treatment activism. See the paper entitled “Joint Advocacy on HIV/AIDS Treatments, Microbicides and Vaccines — … Read more

HIV/AIDS Policy and Law Review 8(3) December 2003

FEATURES TRIPS from Doha to Cancún … to Ottawa: global developments in access to treatment and Canada’s Bill C-56 Warsaw Declaration on HIV/AIDS and injection drug use adopted CANADIAN NEWS North America’s first supervised injection site opens in Vancouver Ontario: People can now apply for forced HIV testing in certain situations Many people in marginalized … Read more

TRIPS from Doha to Cancún . . . to Ottawa: global developments in access to treatment and Canada’s Bill C-56 — HIV/AIDS Policy & Law Review 8(3)

In November 2003, Canada introduced legislation to amend the Patent Act so that manufacturers could obtain licences to make generic versions of patented pharmaceutical products for export to countries lacking sufficient capacity to produce their own. This article provides an overview of recent global developments leading up to Canada’s initiative, as well as an analysis … Read more